Company Overview
- Website
- epivaxonco.com
- Phone
- (646) 905-3964
- Employees
- 4
- Industry
- BioTech/Drugs
- SIC Code
-
8731 - Commercial Physical and Biological Research
Financials & Stats
Revenue
$3B
Recent News & Media
ENERGIZE: a Phase III study of neoadjuvant chemotherapy alone or with nivolumab with/without linrodostat mesylate for muscle-invasive bladder cancer
- Feb 2, 2024
- tandfonline.com
Definitions, End Points, and Clinical Trial Designs for Bladder Cancer: Recommendations From the Society for Immunotherapy of Cancer and the International Bladder Cancer Group
- Oct 4, 2023
- ascopubs.org
Single-cell analysis of localized prostate cancer patients links high Gleason score with an immunosuppressive profile
- Mar 29, 2023
- onlinelibrary.wiley.com
Avelumab Plus Axitinib as First-Line Therapy for Advanced Renal Cell Carcinoma: Long-Term Results from the JAVELIN Renal 100 Phase Ib Trial
- Dec 28, 2022
- pmc.ncbi.nlm.nih.gov
Many Older Patients Not Getting Recommended Treatment for Early-Stage Bladder Cancer, Study Finds
- Nov 10, 2020
- nyulangone.org
Better Epitope Discovery, Precision Immune Engineering, and Accelerated Vaccine Design Using Immunoinformatics Tools
- Apr 7, 2020
- pubmed.ncbi.nlm.nih.gov
Who is Epivax Oncology
EpiVax Oncology is a small, privately held biotechnology company based in New York, New York. With a team of four employees, they generate approximately $2.5 million in annual revenue. EpiVax Oncology is dedicated to developing innovative cancer treatments tailored to individual patients. Their focus lies in precision cancer immunotherapies using a novel approach called mutanome-directed neo-epitopes. This involves identifying unique mutations within a patient's tumor, which are then used to design personalized therapeutic vaccines. These vaccines aim to trigger a potent and specific immune response against cancerous cells, leading to improved clinical outcomes. EpiVax Oncology distinguishes itself through its proprietary in silico predictive algorithms, which play a crucial role in identifying and selecting the most effective neo-epitopes for each patient's treatment. The company leverages its extensive expertise in computational immunology, genomics, and vaccine design, accumulated over two decades. EpiVax Oncology can be reached through their website at epivaxonco.com.
Company Leadership
Epivax Oncology Industry Tags
Companies Similar to Epivax Oncology
Analyze industry trends and opportunities by examining competitors and companies comparable to Epivax Oncology, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 3M | 2 | Cambridge, MA | 2005 | |
| 3M | 7 | New York, NY | 2008 | |
| 3M | 3 | New York, NY | ||
| 3M | 2 | Knoxville, TN | 2004 | |
| 3M | 35 | Austin, TX |